Abstract
More than 50% of children with chronic hepatitis B do not respond to treatment with alpha-interferon. Since these patients continue to display high viral replication and progressive liver disease, retreatment should be considered. To date it has not been well evaluated whether a second course of treatment could increase the response rate. In two alpha-interferon retreatment trials in adult patients the response rate, defined by seroconversion from HBeAg to anti-HBe, ranged between 11% and 44%. One beta-interferon retreatment study in children reported a seroconversion rate of 32%. Regrettably, none of the studies included a control group observing the ‘spontaneous’ seroconversion rate after a first interferon cycle. Thus, a nonrandomized alpha-interferon retreatment study in children including control patients was performed. Alpha-interferon for retreatment was administered 3 times a week for 16–24 weeks in 15 children (5–16 years) at least 6 months after ceasing the first cycle. Four children received 5 MU/m2 of a natural alpha-interferon and 11 children 9 MU/m2 recombinant alpha-interferon 2b. Follow up was 18–47 months after initial treatment. In parallel, a control group of 19 un-retreated children with comparable clinical and demographic data was followed for 12–39 months. HBeAg seroconversion was observed in 5 (33%) of the retreated children and in 5 (26%) of the control patients during follow up. The difference is not significant. In the initially nonresponding children, those with high ALT levels before the first treatment showed late HBeAg seroconversion more frequently than those with low ALT levels (P = 0.017) irrespective of retreatment. The ALT level before retreatment was not a predictor for response.
Conclusions
A second cycle of alpha-interferon during the 3 years following the first treatment in nonresponding children with chronic hepatitis B can be safely performed but did not increase HBeAg/anti-HBe seroconversion compared with the spontaneous seroconversion rate of patients without retreatment.
Similar content being viewed by others
Abbreviations
- ALT:
-
alanine aminotransferase
- AST:
-
aspartate aminotransferase
- CAH:
-
chronic active hepatitis
- CPH:
-
chronic persistent hepatitis
- HBsAg:
-
hepatitis B surface antigen
- HBeAg:
-
hepatitis e antigen
- Anti-HBe:
-
antibodies against HBeAg
- HBV:
-
hepatitis B virus
- HCV:
-
hepatitis C virus
- IFN:
-
interferon
- MU:
-
mega units
References
Barbara C, Bortolotti F, Crivellaro C, Coscia A, Zancan L, Cadrobbi P, Nebbia G (1994) Recombinant interferon-alpha 2a hastens the rate of HBeAg clearence in children with chronic hepatitis B. Hepatology 20:287–290
Bortolotti F, Cadrobbi P, Crivellaro C, Guido M, Rugge M, Noventa F, Calzia R (1990) Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 99:805–810
Conjeevaram HS, Di Bisceglie AM (1995) Management of chronic viral hepatitis in children. J Pediatr Gastroenterol Nutr 20:365–375
De Man RA, Heijtink RA, Niesters HGM, Schalm SW (1995) New developments in antiviral therapy for chronic hepatitis B infection. Scand J Gastroenterol 30 [Suppl 212]:100–104
Hope RL, Weltman M, Dingley J, Fiatarone J, Hope AH, Craig PI, Grierson JM (1995) Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response. Med J Aust 162:8–11
Janssen HLA, Schalm SW, Berk L, de Man RA, Heijtink RA (1993) Repeated courses of α-interferon for treatment of chronic hepatitis type B. J Hepatol 17[Suppl 3]:S47-S51
Jonas MM (1996) Interferon-α for viral hepatitis. J Pediatr Gastroenterol Nutr 23:93–106
Lok AS, Chung H-T, Liu VWS, Ma OCK (1993) Long-term follow up of chronic hepatitis B patients treated with interferon alpha. Gastroenterology 105:1833–1838
Ruiz-Moreno M, Fernandez P, Leal A, Bartolome J, Castillo I, Oliva H, Carreno V (1997) Pilot interferon-beta trial in children with chronic hepatitis B who had previously not responded to interferon therapy. Pediatrics 99:222–225
SokalEM, Wirth S, Goyens P, Depreterre A, Cornu C (1993) Interferon alfa-2b therapy in children with chronic hepatitis B. Gut [Suppl]:S87–S90
Teuber G, Dienes H-P, Meyerzum Büschenfelde K-H, Gerken G (1995) Interferon-α-Retherapie der chronischen Hepatitis-B und -C-Virusinfektion. Z Gastroenterol 33:94–98
Wirth S, Schneider A, Bahn A, Pohlenz J, Lausch E, Gerken G (1994) Interferon therapy in children with chronic hepatitis B (Abstract). Hepatology 20:87A
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ballauff, A., Schneider, T., Gerner, P. et al. Safety and efficacy of interferon retreatment in children with chronic hepatitis B. Eur J Pediatr 157, 382–385 (1998). https://doi.org/10.1007/s004310050834
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s004310050834